Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Nasdaq Stockholm Streamlines Dual Listing Process for US-Listed Companies to access European markets
09:00am, Monday, 02'nd Dec 2024
STOCKHOLM, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announced today an update to the Nasdaq Stockholm Main Market rulebook, effective from 1 January 2025. This update will streamline th
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Monday, 02'nd Dec 2024
NEWTON, Mass. , Dec. 2, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company
The Nasdaq Composite is a comprehensive technology-focused index that tracks the performance of more than 3,000 stocks listed on the exchange. Earlier this month, the index hit (another) all-time high
Notice of Delisting and Re-Compliance of Nasdaq Listing Rule
12:41am, Saturday, 30'th Nov 2024
HONG KONG, Nov. 30, 2024 (GLOBE NEWSWIRE) -- On November 21, 2024, Primega Group Holdings Limited (Nasdaq: PGHL) (the “Company”), was notified by Nasdaq Listing Qualifications Staff of the Nasdaq
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
04:44pm, Friday, 29'th Nov 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 29'th Nov 2024
BOSTON, Mass., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:10pm, Friday, 29'th Nov 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on November 29, 2024 (the “Grant Date�
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 29'th Nov 2024
BOSTON, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on November 29, 2024
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01:30pm, Friday, 29'th Nov 2024
SAN FRANCISCO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercializat
Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan
09:55am, Friday, 29'th Nov 2024
SEATTLE, WA / ACCESSWIRE / November 29, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock split of its outstanding shares
Jianzhi Receives Good News from Nasdaq
09:15am, Friday, 29'th Nov 2024
BEIJING, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (NASDAQ: JZ), a leading provider of digital educational content in Ch
Millicom (Tigo) intends to consolidate listing of shares on NASDAQ U.S. by delisting SDRs from Nasdaq Stockholm and resumes shareholder remuneration
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06:00am, Friday, 29'th Nov 2024
SOUTH SAN FRANCISCO, Calif. , Nov. 29, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therap
S&P 500, Nasdaq slide after key Fed inflation gauge shows faltering progress
05:30pm, Wednesday, 27'th Nov 2024
To get the latest market news check out finance.yahoo.com US stocks dipped Wednesday as investors digested fresh data that showed inflation made little progress toward the Fed's 2% target in October.
Nvidia leads Nasdaq lower
05:30pm, Wednesday, 27'th Nov 2024
To get the latest market news check out finance.yahoo.com Nvidia (NVDA) stock slipped more than 3% on Wednesday, weighing on the Nasdaq 100 (^NDX). Shares in the AI chip giant are off about 9% in the
